Bronchial Hyperresponsiveness in Pediatric Non‐Cystic Fibrosis Bronchiectasis
Pediatric Pulmonology · 2026
DOI: 10.1002/ppul.71839 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Pulmonology, 2026. Verfasst von Lisa Gerbeau und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Pulmonology Department, University Hospital La Timone Enfants, Marseille, France. Hauptthemen laut MEDLINE: Asthma, Bronchial Hyperreactivity, Bronchiectasis. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
The prevalence and significance of bronchial hyperresponsiveness (BHR) in patients with non‐cystic fibrosis (CF) bronchiectasis remain unclear. The objective is to determine the prevalence of BHR, defined as a post‐bronchodilator forced expiratory volume in 1 s (FEV1) improvement > 10%, in children with non‐CF bronchiectasis and to assess its association with clinical, functional, and radiological characteristics.
Design
This retrospective, observational monocentric study included children with non‐CF bronchiectasis followed‐up at an university center for rare pediatric respiratory diseases. Patients Patients were eligible if they had performed spirometry with bronchodilator reversibility testing within 3 years of a diagnostic chest computed tomography (CT). Main Outcomes Measures Asthma symptoms, asthma exacerbations, asthma treatments, allergic markers, infectious exacerbations, causes of bronchiectasis, FEV1, FEV1/forced vital capacity (FVC) ratio, reversibility, and mosaic attenuation on CT were compared between patients with and without BHR.
Results
Among 157 patients, 65 (male/female sex ratio 0.71, mean age 10 years old, asthma symptoms in over 56% of patients, 67% treated with inhaled corticosteroids) met the inclusion criteria. BHR was present in 32.3% of cases. Patients with BHR had a significantly altered lung function (baseline Z‐score FEV1 −2.12 vs −0.87; FEV1/FVC −2.28 vs −0.85). No significant association was found between BHR and clinical and radiological characteristics.
Conclusion
BHR is not associated with clinical, radiological or therapeutic characteristics in pediatric non‐CF bronchiectasis, except a more severe airflow limitation. These findings highlight the importance of lung function assessment for non‐CF bronchiectasis patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatric Pulmonology Department, University Hospital La Timone Enfants, Marseille, France.
- Unit of pediatric Pulmonary Function Testing, La Timone Enfants, Marseille, France.
- Pediatric Radiology Department, University Hospital La Timone Enfants, Marseille, France.
- Pediatric Department, University Hospital La Timone Enfants, Marseille, France.
- Aix-Marseille University, Marseille, France.
ORCID-Profile: Lisa Gerbeau, Julie Mazenq
Zitieren
APA
Gerbeau, L., Finet, A., Bertrand, M., Bosdure, E., Papazian, L., Tahiri, K., Baravalle, M., Mazenq, J., & Dubus, J. C. (2026). Bronchial Hyperresponsiveness in Pediatric Non‐Cystic Fibrosis Bronchiectasis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71839
Vancouver
Gerbeau L, Finet A, Bertrand M, Bosdure E, Papazian L, Tahiri K, et al. Bronchial Hyperresponsiveness in Pediatric Non‐Cystic Fibrosis Bronchiectasis. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71839
BibTeX
@article{Gerbeau2026,
author = {Gerbeau, Lisa and Finet, Armelle and Bertrand, Margaux and Bosdure, Emmanuelle and Papazian, Laura and Tahiri, Kenza and Baravalle, Melisande and Mazenq, Julie and Dubus, Jean-Christophe},
title = {Bronchial Hyperresponsiveness in Pediatric Non‐Cystic Fibrosis Bronchiectasis},
journal = {Pediatric Pulmonology},
year = {2026},
doi = {10.1002/ppul.71839}
}
EUVIMED